# China NMPA Drug Inspection - Hunan Nanguo Yaodu Traditional Chinese Medicine Pieces Co., Ltd. - Ginseng slices

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/hunan-nanguo-yaodu-traditional-chinese-medicine-pieces-co-ltd/52ae1013-1682-4d47-8c38-e58f2fafd449/
Source feed: China

> China NMPA drug inspection for Hunan Nanguo Yaodu Traditional Chinese Medicine Pieces Co., Ltd. published December 23, 2019. Drug: Ginseng slices. The Guizhou Provincial Drug Administration published an announcement on December 23, 2019, detailing results from its 20

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guizhou Provincial Drug Administration Drug Sampling Inspection Information Bulletin, Issue 4, 2019
- Company Name: Hunan Nanguo Yaodu Traditional Chinese Medicine Pieces Co., Ltd.
- Publication Date: 2019-12-23
- Drug Name: Ginseng slices
- Inspection Finding: Non-compliant: [Inspection]: Moisture content
- Action Taken: Food and drug regulatory authorities at all levels are investigating and handling the matter in accordance with the law, and have taken timely control measures against the relevant drugs.
- Summary: The Guizhou Provincial Drug Administration published an announcement on December 23, 2019, detailing results from its 2019 drug quality sampling plan. This initiative aimed to enhance drug quality oversight and ensure public medication safety. The inspection identified four batches of drugs that did not meet established standards.

Two manufacturers were cited for non-compliance. Lanzhou Heshengtang Pharmaceutical Co., Ltd. had one batch of Compound Acetaminophen Tablets (Batch 20180702) found to be non-compliant with the Disintegration Time standard, referencing the Ministry-issued Standard WS1-67(B)-89 and the 2015 Chinese Pharmacopoeia, Part IV. Hunan Nanguo Yaodu Traditional Chinese Medicine Pieces Co., Ltd. had three products cited: Yam (Batch 180101), Cistanche Tablets (Batch 181201), and Ginseng Slices (Batch 180301). All three traditional Chinese medicine pieces were found to have excessive Moisture content, failing to meet the requirements of Part I of the 2015 Chinese Pharmacopoeia.

Following these findings, food and drug regulatory departments are conducting investigations and taking legal actions against the responsible entities. Timely control measures have also been implemented for the affected drugs to mitigate risks to public health.

Company: https://www.globalkeysolutions.net/companies/hunan-nanguo-yaodu-traditional-chinese-medicine-pieces-co-ltd/e04cc1b0-d451-4d19-bb29-a5d1f15fd19e/